𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic susceptibility in pancreatic ductal adenocarcinoma

✍ Scribed by R. Lochan; A. K. Daly; H. L. Reeves; R. M. Charnley


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
263 KB
Volume
95
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

The strongest risk factors for pancreatic adenocarcinoma are tobacco smoking and increasing age. However, only a few smokers or elderly individuals develop the disease and genetic factors are also likely to be important.

Methods

The literature on genetic factors modifying susceptibility to cancer was reviewed, with particular regard to the interindividual variation that exists in the development of pancreatic adenocarcinoma.

Results

Tobacco-derived carcinogen-metabolizing enzyme gene variants have been the main area of study in stratifying the risk of sporadic pancreatic cancer. Inconsistent results have emerged from the few molecular epidemiological studies performed.

Conclusion

There is great scope for further investigation of critical pathways and unidentified genetic influences may be revealed. This may eventually allow the identification of individuals at high risk who might be targeted for screening.


πŸ“œ SIMILAR VOLUMES


Molecular genetic basis of pancreatic ad
✍ Werner Hilgers; Scott E. Kern πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 1 views

Pancreatic ductal adenocarcinoma is a complex genetic disease. As might be expected for a malignancy that is rather homogeneous in clinical presentation and behavior, a distinct subset of genes are found to be genetically inactivated in a majority of the tumors. A yet larger subset of genes experien

Aberrant methylation of Reprimo correlat
✍ Norihiro Sato; Noriyoshi Fukushima; Hiroyuki Matsubayashi; Christine A. Iacobuzi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 267 KB

## Abstract ## BACKGROUND The p53‐dependent G2/M checkpoint plays a key role in the maintenance of genomic integrity, thereby protecting cells from neoplastic progression. __Reprimo__, a gene involved in the p53‐induced G2 cell cycle arrest, has been recently identified as a novel target for aberr

In vitro pancreatic ductal cell carcinog
✍ Yoshito Ikematsu; Guozhen Liu; Margery A. Fienhold; Martin Cano; Thomas E. Adria πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 463 KB πŸ‘ 2 views

Our experiments were designed to identify initial biochemical and biological changes that occur during pancreatic carcinogenesis. TAKA-1, an immortal hamster pancreatic ductal cell line, was treated in vitro for up to 11 weeks with the pancreatic carcinogen N-nitorosobis(2-oxopropyl)amine (BOP). The